MedPath

The preventive effect of hyoscine butylbromide on catheter-related bladder discomfort in the post-anesthesia care unit

Not Applicable
Completed
Conditions
Not Applicable
Registration Number
KCT0000662
Lead Sponsor
Seoul National University Bundang Hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Male
Target Recruitment
110
Inclusion Criteria

1) Patients whose Foley catheters are newly placed in the operating room and are planned to be kept for 6 hours or more.
2) Male patients
3) 20- to 75-year-old patients that have 14 Fr. or more sized Foley catheters.
4) American Society of Anesthesiologists class 1 or 2
5) patients from whom informed consents were obtained.

Exclusion Criteria

1) Neurogenic bladder
2) overactive bladder
3) those that are hyper-sensitive or contra-indicated to the study drug
4) those that have central nerveous system or renal disorder
5) those that have neurologic disease

Study & Design

Study Type
Interventional Study
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
incidence and severity of CRBD
Secondary Outcome Measures
NameTimeMethod
postoperative nausea and vomitting ;Rescue antiemetics;Dry mouth ;Facial flushing ;Blurred vision ;postoperative pain (VAS);rescue analgesic ;Total amount of analgesics including PCA administered for 6 hours after administration of hyoscine butylbromide
© Copyright 2025. All Rights Reserved by MedPath